Analgesic efficacy of erector spinae plane block in patients undergoing major gynecologic surgery: A randomized controlled study
Authors' conclusion
ESPB did not reduce opioid consumption during the 24 h postoperative but attenuated pain intensity during the early period after surgery.
Study context
- Population
- Women undergoing major surgery with long midline incision for gynecologic malignancy, tertiary university hospital, February 2022 to January 2023
- Participants
- 88 women
- Comparison
- ESP block vs standard systemic analgesia
- Primary endpoint
- Cumulative opioid consumption
- Follow-up
- 24 h postoperatively
Methodological detailssingle-centre, patient-assessor blinded
- Single-centre
- Patient-assessor blinded
Primary result
As reported in the abstract
Mean difference
5.5 mg
95% CI −1.7 to 12.8
P = 0.128
By group
ESPB vs Control
mean difference 5.5 mg (95% CI −1.7 to 12.8); P = 0.128
Secondary outcomes
| Outcome | Median difference (95% CI) | P value | |
|---|---|---|---|
| Patient satisfaction regarding analgesia · 24 h postoperativeSignificantly higher in the ESPB group | −1 (−3 to 0) | P = 0.038 | |
| −4−202Difference (linear scale) |
Postoperative recovery variables
- No significant differences
Original publication
Analgesic efficacy of erector spinae plane block in patients undergoing major gynecologic surgery: A randomized controlled study. J Clin Anesth. Published 26 December 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →